NRX-0305: A Pan-Mutant Brain-Penetrant BRAF Degrader with Broad Preclinical Activity and Synergy with MEKi in Class 1/2/3 BRAF-Mutant Cancers By webmaster / September 23, 2025
NRX-0305: A Pan-Mutant BRAF Degrader with Broad Preclinical Efficacy, Brain Penetrance, and Synergistic Potential with MEK Inhibition Across Class 1/2/3 BRAF-mutant Cancers By webmaster / April 25, 2025
An Orally Bioavailable, Brain Penetrant, Pan-Mutant BRAF Degrader For The Treatment Of Primary And Inhibitor-Resistant Solid Tumors By aterrado@waterhousebrands.com / January 7, 2025
